- Release Date: 11/07/23 12:35
- Summary: EBITDA Guidance Update FY23 and FY24
- Price Sensitive: Yes
- Download Document 74.5KB
- Forums
- ASX - By Stock
- MP1
- Ann: EBITDA Guidance Update FY23 and FY24
Ann: EBITDA Guidance Update FY23 and FY24
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MP1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$8.36 |
Change
0.260(3.21%) |
Mkt cap ! $1.344B |
Open | High | Low | Value | Volume |
$8.16 | $8.47 | $8.10 | $16.04M | 1.919M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 11831 | $8.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.39 | 1827 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 14799 | 8.350 |
5 | 12198 | 8.340 |
1 | 1000 | 8.330 |
2 | 4733 | 8.320 |
4 | 12559 | 8.310 |
Price($) | Vol. | No. |
---|---|---|
8.360 | 9226 | 3 |
8.370 | 3453 | 3 |
8.380 | 25310 | 7 |
8.390 | 10377 | 5 |
8.400 | 22480 | 6 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
MP1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online